Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 21,816 shares at $47.82 ($1.0M) on 2020-04-09, disclosed to the SEC on 2020-04-13.
Open-market sale of $1.0M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.81 | 5,982 | $280K | 27.1% |
| 2 | $46.81 | 5,982 | $280K | 27.1% |
| 3 | $47.82 | 3,626 | $173K | 16.8% |
| 4 | $47.82 | 3,626 | $173K | 16.8% |
| 5 | $48.75 | 1,892 | $92K | 8.9% |
| 6 | $48.44 | 200 |
| $10K |
| 0.9% |
| 7 | $49.87 | 200 | $10K | 1.0% |
| 8 | $51.22 | 308 | $16K | 1.5% |
| Total | $47.42 avg | 21,816 | $1.0M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |